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SUMMARY 22 
Chronic infections by the hepatotropic viruses hepatitis B virus (HBV) and 23 
hepatitis C virus (HCV) are major risk factors for the development of 24 
hepatocellular carcinoma (HCC). It is estimated that more than 700,000 25 
individuals per year die from hepatocellular carcinoma, and around 80% of 26 
HCC is attributable to HBV or HCV infection. Despite the clear clinical 27 
importance of virus-associated HCC, the underlying molecular mechanisms 28 
remain largely elusive. 29 
 30 
Oxidative stress, in particular DNA lesions associated with oxidative damage, 31 
play a major contributory role in carcinogenesis, and are strongly linked to the 32 
development of many cancers, including HCC. A large body of evidence 33 
demonstrates that both HBV and HCV induce hepatic oxidative stress, with 34 
increased oxidative DNA damage being observed both in infected individuals 35 
and in murine models of infection.  36 
 37 
Here, we review the impact of HBV and HCV on the incidence and repair of 38 
oxidative DNA damage. We begin by giving a brief overview of oxidative 39 
stress and the repair of DNA lesions induced by oxidative stress. We then 40 
review in detail the evidence surrounding the mechanisms by which both 41 
viruses stimulate oxidative stress, before focusing on how the viral proteins 42 
themselves may perturb the cellular response to oxidative DNA damage, 43 
impacting upon genome stability and thus hepatocarcinogenesis. 44 
 45 
 46 
47 
INTRODUCTION 48 
Hepatocellular carcinoma (HCC) is an increasing global health 49 
problem, accounting for more than 90% of primary liver tumours. Worldwide, 50 
HCC is the third cause of cancer-related death, responsible for 700,000 51 
deaths per year (Ferlay et al., 2010), and the sixth most common cancer. 52 
Chronic infections with hepatitis B virus (HBV) and hepatitis C virus (HCV) are 53 
major risk factors for the onset and progression of HCC (El-Serag, 2002; 54 
Simonetti et al., 1992).  Globally, up to 80% of hepatocellular carcinoma is 55 
attributable to HBV or HCV infection (Perz et al., 2006). The underlying 56 
mechanisms remain unclear, although an increasing body of evidence 57 
suggests that the viral proteins themselves may contribute directly to 58 
tumourigenesis.  59 
Timely and precise repair of DNA lesions is crucial for the maintenance 60 
of genome stability. Since genomic instability is a characteristic of all tumours, 61 
DNA damage recognition and repair processes represent an important barrier 62 
to the initiation and progression of tumourigenesis. Cells in multicellular 63 
organisms are continuously exposed to DNA damage arising from a variety of 64 
endogenous and exogenous sources. These include reactive oxygen species, 65 
ultraviolet light, background radiation, and environmental mutagens. In 66 
particular, oxidative stress and elevated reactive oxygen species (ROS) levels 67 
are linked with number of human diseases.  ROS that accumulate as a result 68 
of oxidative stress can directly react with DNA molecules to produce a variety 69 
of oxidative DNA lesions, whose repair by components of the base excision 70 
repair (BER) and nucleotide excision repair (NER) pathways is crucial in 71 
maintaining genome stability. 72 
Oxidative DNA damage may play a pivotal role in 73 
hepatocarcinogenesis associated with chronic viral infection. A growing 74 
number of publications have concluded that chronic HBV and HCV infection 75 
correlates with an increased incidence of oxidative DNA damage (Bolukbas et 76 
al., 2005; Demirdag et al., 2003; Farinati et al., 2007a; Fujita et al., 2008; 77 
Machida et al., 2006; Nishina et al., 2008). Whilst it is clear that ROS are 78 
continuously generated during chronic inflammation over the course of 79 
chronic viral infection, increasing evidence suggests that the viral proteins of 80 
HBV and HCV may themselves contribute to a state of chronic oxidative 81 
stress in infected hepatocytes.  82 
In this review, we will summarise the current knowledge surrounding 83 
oxidative stress and DNA damage during hepatotropic viral infection. We will 84 
compare and contrast the mechanisms by which the proteins encoded by 85 
HBV and HCV induce oxidative stress, before providing an overview of the 86 
impact of these viral proteins on oxidative DNA damage and repair, and briefly 87 
examining the ultimate consequences on the development of HCC.  88 
 89 
OXIDATIVE STRESS 90 
Reactive oxygen species may arise by exposure to exogenous agents 91 
such as ionizing radiation or drugs, or may be generated from endogenous 92 
sources such as metabolism, apoptosis or inflammation. Oxidative stress 93 
represents a shifting of the balance between oxidants (such as ROS) and the 94 
cellular antioxidant response, leading to potential cellular damage and 95 
contributing to disease. Cells are able to withstand a relatively low level of 96 
oxidative damage. However, sustained oxidative stress, arising through the 97 
increased presence of radicals and ROS, or by a lack of antioxidant capacity 98 
within the cell, will engender increased damage to lipids, proteins and DNA. A 99 
detailed description of the repair of oxidative DNA damage is covered in a 100 
subsequent section.  ROS are primarily generated in the mitochondria as by-101 
products of cellular metabolism, through electron leakage from the 102 
mitochondrial electron transport chain. However, they also play a key role as 103 
second messengers in cellular signalling. ROS-induced damage may 104 
influence pathway signalling, gene expression, cell cycle, metabolism, and 105 
apoptosis. Oxidative stress may also activate oncogenic signalling pathways, 106 
ultimately contributing to cellular transformation (Hussain et al., 2003).  107 
 108 
Viral infection and oxidative stress: non-specific inflammation  109 
Although this review focuses on how the HBV and HCV viral proteins 110 
induce oxidative stress, it is clear that chronic infection by either virus triggers 111 
a non-specific immune-mediated inflammation (hepatitis), which is innately 112 
linked to oxidative stress. During acute liver injury and hepatic inflammation, 113 
ROS are generated by both neutrophils and Kupffer cells (reviewed by 114 
(Jaeschke, 2011)), as the principal toxic mediators to induce cell death. Since 115 
these cells exist in close proximity to hepatocytes, some ROS (i.e. H2O2) are 116 
able to diffuse into hepatocytes, although the plasma membrane represents a 117 
barrier to the free diffusion of O2.-. Membrane superoxide dismutases are able 118 
to convert these O2.- anions to H2O2 in the extracellular space, which are then 119 
able to cross membranes and elicit intracellular signalling (Fisher, 2009). 120 
Thus, these ROS will enhance and amplify the intracellular effects 121 
engendered by the viral proteins themselves, and will also affect neighbouring 122 
(uninfected) hepatocytes (Jaeschke, 2011), although they may also serve to 123 
activate intracellular antioxidant defences. Moreover,  mitochondrial reactive 124 
oxygen species are able to drive proinflammatory cytokine production (Naik & 125 
Dixit, 2011), further exacerbating both inflammation and the production of 126 
ROS.  127 
 128 
OXIDATIVE DNA DAMAGE AND REPAIR 129 
ROS may directly interact with DNA to induce oxidative DNA damage. 130 
Oxidative DNA lesions may comprise abasic sites, deaminated or adducted 131 
bases, and single stranded DNA breaks (SSBs). These lesions include 132 
thymine and thymidine glycol, 5-hydroxylmethyluracil, and 8-hydroxy-133 
deoxyguanosine (8-OHdG). The latter represents the most widely studied of 134 
oxidative DNA lesions, and is used as a robust marker of oxidative DNA 135 
damage. The accumulation of oxidative DNA lesions is considered mutagenic, 136 
and a significant contributory factor to human disease (reviewed by 137 
(Sedelnikova et al., 2010)).  138 
The majority of oxidative DNA lesions are repaired by components of 139 
the base excision repair pathway (BER), and to a lesser extent, by nucleotide 140 
excision repair (NER). The rate of transient oxidative DNA damage is typically 141 
balanced by its rate of repair, but chronic oxidative stress may result in 142 
permanent genetic damage. Since there are multiple, overlapping pathways 143 
for the repair of oxidative DNA damage, perturbation of one component of 144 
these pathways is expected to slow but not abolish repair.  145 
Base excision repair (Figure 1) is initiated by a DNA glycosylase that 146 
recognizes and removes the damaged base, generating either a SSB or an 147 
abasic site which requires further processing by an AP endonuclease (APE1). 148 
The resultant SSB may be repaired by two alternate pathways: short-patch 149 
BER (Figure 1, bottom right), involving Pol β and the DNA ligase III/XRCC1 150 
complex, which inserts a single nucleotide; or long-patch BER (Figure 1, 151 
bottom left), which replaces 2-12 nucleotides, and is dependent upon PCNA 152 
and Flap Endonuclease 1 (Fen1), and may involve several polymerases (Pol 153 
β, δ and ε). Τhe factors governing the choice of long- or short-patch BER 154 
remain unclear. 155 
The nucleotide excision repair (NER) pathway (Figure 2), which is 156 
generally associated with repair of bulky, helix-distorting adducts, is also able 157 
to repair oxidative DNA lesions, albeit to a lesser extent. Detection of bulky 158 
lesions, whether in actively transcribed regions (right, panel) or not (left panel) 159 
(see Figure 2 for details), leads to recruitment of the TFIIH complex to sites of 160 
damage. Members of the TFIIH complex facilitates helix unwinding and 161 
excision of the strand containing the adduct, and repair is completed by 162 
several proteins which complete gap-filling/ligation. NER is capable of 163 
removing all of the oxidative lesions induced by ROS (Kuraoka et al., 2000; 164 
Reardon et al., 1997), as NER initiating factors (CSA, CSB, XPC and XPE) 165 
rapidly bind to oxidative lesions (Menoni et al., 2012). However, the overall 166 
contribution of NER to the repair of oxidative lesions remains to be 167 
determined, and it is likely that NER acts as a backup pathway to BER. 168 
Interestingly, oxidative stress generated by activated neutrophils, and 169 
potentially by kuppfer cells, results in a reduction in nucleotide excision repair 170 
(NER) capacity, suggesting that inflammation may non-specifically reduce 171 
NER efficiency (Gungor et al., 2007). 172 
In some circumstances oxidative DNA damage may result in double 173 
strand break (DSB) formation, especially if lesions are clustered together on 174 
opposite strands. Although DSBs will arise at a lower frequency to SSBs, their 175 
rapid repair is crucial to maintaining genetic stability. Repair of DSBs involves 176 
either recombination using homologous sequences from undamaged sister 177 
chromatids (homologous recombination; HR), or non-homologous end-joining 178 
(NHEJ), which can result in small deletions. For a comprehensive view on 179 
DSB repair, the reader is directed to an excellent recent review by (Chapman 180 
et al., 2012). 181 
In addition, a growing body of literature suggests that cellular tumour 182 
suppressors, including those involved in repair of other types of DNA lesions, 183 
may play a vital role in regulating oxidative stress. p53 is activated in 184 
response to oxidative stress, and is thought to play an antioxidant role in such 185 
circumstances. Regulation of both pro- and anti-oxidant genes by p53 is 186 
thought to be crucial in regulating the cellular response and cell fate to acute 187 
oxidative stress (reviewed in (Vurusaner et al., 2012)). Moreover, the breast 188 
cancer susceptibility genes BRCA1 and BRCA2, involved in DNA repair and 189 
cell cycle checkpoint progression, also play caretaker roles against oxidative 190 
stress. In particular, in response to oxidative stress, BRCA1 upregulates the 191 
expression of numerous antioxidant genes (e.g. glutathione-S-transferase, 192 
alcohol dehydrogenases) (Bae et al., 2004). BRCA1 over-expression protects 193 
against oxidising agents, maintaining the cellular redox balance in the face of 194 
oxidative stress. Similarly, BRCA1 may enhance the activity of the antioxidant 195 
transcription factor Nrf2 (Ishikawa et al., 2005). In addition to its well-196 
characterised role in the repair of DSBs by promoting HR, BRCA2 is also 197 
critical for the repair of oxidative lesions. Specifically, BRCA2 (as well as 198 
BRCA1) is required for the transcription-coupled repair of 8-OHdG lesions, 199 
crucial for the prevention of transcription stalling and subsequent mutagenesis 200 
(Bae et al., 2004; Le Page et al., 2000).  201 
Thus, members of multiple, overlapping and functionally diverse 202 
pathways (namely BER, NER and DSB repair) are required for the effective 203 
repair of oxidative DNA lesions resulting from oxidative stress. 204 
 205 
HBV, OXIDATIVE STRESS AND DNA DAMAGE 206 
HBV infection and oxidative stress 207 
HBV is one of several closely-related DNA viruses within the family 208 
Hepadnaviridiae. The viral genome encodes a small number of gene 209 
products: a reverse transcriptase and DNA polymerase (pol); a capsid protein 210 
(core); envelope proteins L, M and S; and a multifunctional protein (X) 211 
involved in replication, oncogenesis, and a myriad of other cellular metabolic 212 
dysfunctions. Replication of HBV is complex and proceeds via the reverse 213 
transcription of genome-length RNA; thus, HBV is classified as a dsDNA 214 
retrovirus (group VII).  215 
 Chronic HBV infection is a major etiological factor for HCC: the risk of 216 
HCC development in chronic HBV carriers is more than 100-fold greater than 217 
in uninfected individuals (Ito et al., 2010). The vast majority of new cases of 218 
HBV-associated HCC occur in developing countries, especially sub-Saharan 219 
Africa and Southeast Asia. Although HCC generally occurs in cirrhotic livers, 220 
HBV is also able to transform hepatocytes in the absence of chronic 221 
inflammation and cirrhosis (Brechot, 2004). During chronic infection, 222 
fragments of HBV DNA may integrate into the host genome, preferentially into 223 
chromosome 17, creating mutations. These integrated fragments often 224 
encode the X protein of HBV (HBx) or truncated preS proteins, the integration 225 
of which often correlates with hepatocarcinogenesis (Ding et al., 2012) . 226 
Several groups have shown that HBV infection is associated with 227 
oxidative stress in chronically-infected individuals (Bolukbas et al., 2005; 228 
Demirdag et al., 2003). Both lipid peroxidation and oxidative DNA damage, 229 
markers of oxidative stress, are elevated in patients infected with HBV. 230 
Indeed, patients with chronic HBV infection exhibit increased 8-OHdG 231 
accumulation (Fujita et al., 2008). Furthermore, in vitro HBV replication in 232 
hepatoma cell lines (specifically HepAD38 cells) induces oxidative stress 233 
(Severi et al., 2006). 234 
A direct role for HBV-encoded proteins in oxidative stress 235 
In addition to non-specific oxidative stress generated by local 236 
inflammation in response to viral infection, increasing evidence suggests that 237 
the HBV proteins directly regulate cellular ROS production (Figure 3 upper 238 
panel), and deleteriously alter intracellular antioxidant defences in HBV-239 
infected cells, causing apoptosis and extensive liver damage and thus 240 
engendering accelerated hepatocellular renewal. However, the consequences 241 
of these interactions and their impact are yet to be fully understood.  242 
Over a decade ago, HBx was shown to localise to mitochondria, 243 
decreasing mitochondrial membrane potential, and increasing both 244 
cytochrome c release and apoptosis (Takada et al., 1999). Moreover, 245 
transgenic mice expressing the HBV proteins (including HBx) also display 246 
elevated hepatic oxidative stress levels compared to nontransgenic controls, 247 
with a concurrent increase in oxidative DNA damage (Hagen et al., 1994). 248 
These findings were extended to demonstrate that ROS scavengers were 249 
able to inhibit HBx-mediated mitochondrial membrane depolarisation and 250 
subsequent apoptosis (Shirakata & Koike, 2003). In agreement, Lee and 251 
colleagues demonstrated that HBx alters mitochondrial membrane potential, 252 
perturbs mitochondrial electron transport, affects hepatocyte metabolism and 253 
increases cellular ROS production (Lee et al., 2004). HBx has accordingly 254 
been reported to sensitise cells to apoptosis induced by oxidative stress, 255 
mainly through loss of the anti-apoptotic protein Mcl-1 (Hu et al., 2011). In 256 
general agreement, HBx was shown to induce apoptosis through regulation of 257 
Bcl-XL and Bax (Kim et al., 2008; Miao et al., 2006). It is therefore clear that 258 
expression of HBx stimulates intracellular ROS production and impacts upon 259 
apoptosis. 260 
The HBV surface antigen (HBsAg) and associated PreS region have 261 
also been associated with oxidative stress. Expression of truncated mutants 262 
of the HBV PreS/S polypeptide in hepatoma (Huh7) cells induced production 263 
of ROS via ER-stress pathways, resulting in oxidative DNA damage (Hsieh et 264 
al., 2004; Wang et al., 2005), although these results might be strongly 265 
influenced by non-specific ER stress triggered by high levels of HBV protein 266 
expression. Hsieh et al. (2004) also showed that transgenic mice expressing 267 
these mutants exhibited elevated oxidative DNA damage and up-regulated 268 
expression of Ogg1, the DNA glycosylase mainly responsible for the repair of 269 
8-OHdG lesions. Such oxidative damage may play an important role in 270 
hepatocarcinogenesis associated with HBV infections, illustrated by elevated 271 
nodular profileration and increased tumour development in mice expressing 272 
PreS mutants (Wang et al., 2005). In contradiction, examination of a small 273 
cohort of patients (n=38) failed to reveal a link between PreS mutation and 274 
increased oxidative stress in HBV-infected patients, although HBV infection 275 
was again linked to elevated levels of 8-OHdG and Ogg1 expression (Gwak et 276 
al., 2008). 277 
Given these data, one would expect that intracellular antioxidant 278 
defences would be activated in the presence of the HBV proteins. 279 
Accordingly, HBV upregulates the expression of cytoprotective genes 280 
containing antioxidant response elements (AREs), both in vitro and in HBV-281 
infected liver tissues (Schaedler et al., 2010). However, Schaedler and co-282 
workers demonstrated that this upregulation was independent of ROS, and, in 283 
contrast to other studies, suggested that this upregulation might confer 284 
survival benefits upon HBV-infected cells, allowing them to survive the 285 
sustained oxidative stress found in the infected liver. The discrepancy of 286 
Schaedler’s findings with other published data (described above) emphasises 287 
the difficulty of studying changes in the redox balance occurring during a 288 
natural HBV infection, and questions the relevance of using HBV models 289 
usually devoid of an immune response.   290 
These studies demonstrate that HBV infection induces extensive 291 
oxidative stress and activates intracellular oxidative repair pathways, and 292 
suggest that HBx expression (and perhaps that of PreS) is, in part, 293 
responsible. However, certain aspects require further clarification, and may be 294 
addressed by controlling the level of HBV protein expression to more closely 295 
resemble that observed in infected individuals and by validating the results in 296 
the context of the whole HBV genome. Although antioxidant treatments seem 297 
a promising avenue of therapeutic research for HBV infection, their efficacy is 298 
as yet unknown. 299 
HBV and oxidative DNA damage 300 
As detailed above, HBV infection, HBx and PreS induce oxidative 301 
stress, which culminates in increased hepatic oxidative DNA damage, with  302 
increased levels of 8-OHdG found in HBV-infected patients, in transgenic 303 
mice expressing either pre-S mutants or HBx, and in hepatoma cells 304 
expressing HBx (Fujita et al., 2008; Gwak et al., 2008; Hagen et al., 1994). A 305 
number of studies have suggested that the HBV-encoded proteins, in addition 306 
to their role in inducing oxidative stress, may also inhibit cellular DNA repair 307 
pathways. Despite the conflictual nature of some of these reports, we attempt 308 
to summarise the current state-of-knowledge below. 309 
HBV and the repair of oxidative DNA lesions 310 
A growing body of literature suggests that the HBV proteins may alter 311 
the repair of DNA lesions, including oxidative DNA damage (Figure 4). There 312 
are, however, conflicting accounts of the effect of HBV on the base excision 313 
repair pathway. Gwak and colleagues (2008) demonstrated that expression of 314 
Ogg1 was increased in hepatic tissues from HBV-infected patients, regardless 315 
of whether they originated from tumoural or non-tumoural regions (Gwak et 316 
al., 2008). In agreement, expression of Pre-S mutants induced Ogg1 317 
expression in vitro and in murine models (Hsieh et al., 2004). These studies 318 
suggest that infected cells respond to HBV-induced oxidative stress by 319 
upregulating cellular glycosylases involved in BER, activating DNA repair 320 
(Figure 4, left panel). However, recent studies have demonstrated that HBx 321 
inhibits BER initiated by Thymidine glycolsylase (Tdg) (van de Klundert et al., 322 
2012). Whilst this study examined the effects of HBx on BER induced by Tdg 323 
in vitro, the effect of HBx on accumulation of 8-OHdG remains unstudied, as 324 
Tdg acts on G/T mismatches and not on 8-OHdG. 325 
A considerable number of studies report that HBV inhibits NER (Figure 326 
4, right panel). This has in large part been attributed to the HBx protein. Cells 327 
expressing HBx render hepatoma cells more sensitive to UV-C, and HBx 328 
inhibits global NER in a host-cell reactivation assay (Jia et al., 1999; Lee et 329 
al., 2005; Mathonnet et al., 2004). Moreover, HBx inhibits the expression of 330 
the TFIIH subunits XPB and XPD, and interacts with and inhibits the function 331 
of TFIIH, leading to increased UV-C sensitivity of cells expressing HBx 332 
(Jaitovich-Groisman et al., 2001; Qadri et al., 2011). In addition to inhibiting 333 
global NER, HBx may also impede NER within transcriptionally active genes 334 
(transcription-coupled NER) (Mathonnet et al., 2004). However, since the 335 
impact of NER on repair of oxidative DNA damage is unclear (as mentioned 336 
above), the impact of HBx-induced NER inhibition upon oxidative damage 337 
during HBV infection remains to be studied. 338 
As outlined previously, the p53 tumour suppressor is also involved in 339 
the response to oxidative DNA damage. Intriguingly, HBV has been shown to 340 
perturb p53 function (Figure 4, lower panel). The interaction between HBx and 341 
p53 is well established (Chung et al., 2003; Lin et al., 1997; Wang et al., 1994; 342 
Yun et al., 2000), and it seems that this alters the binding of p53 to p53-343 
responsive elements, resulting in aberrant gene expression (Chan et al., 344 
2013). Given these data, one may imagine that interactions between HBx and 345 
p53 would negatively impact the repair of oxidative DNA lesions. 346 
In addition to the specific mechanisms detailed above, the frequent 347 
random integration of HBV DNA into genes encoding DNA repair and 348 
checkpoint proteins (e.g. Wrn, hTERT, Rad17 (Toh et al., 2013)) may also 349 
serve to perturb the cellular response to DNA damage. Furthermore, oxidative 350 
stress may increase the rate of HBV fragment integration in vitro (Dandri et 351 
al., 2002). In agreement with this latter remark, this study also suggests that 352 
the SSB repair factor PARP-1 may play a protective role against HBV DNA 353 
integration, presumably by rapidly repairing breaks which would otherwise 354 
favour integration of exogenous DNA.  355 
From these studies, it is apparent that HBV proteins (notably HBx) 356 
interact with components of both BER and NER pathways, implying that the 357 
function of these pathways in the repair of oxidative lesions may be perturbed 358 
during HBV infection, ultimately contributing to the elevated levels of 8-OHdG 359 
observed in HBV-infected patients.  360 
 361 
HCV, OXIDATIVE STRESS AND DNA DAMAGE 362 
HCV infection and oxidative stress 363 
HCV is a member of the Flaviviridae family of enveloped, positive-364 
single strand RNA viruses. The positive-sense RNA genome acts as a 365 
template for viral genome replication, and is also translated into a polyprotein 366 
which is cleaved by both host and virally-encoded proteases to generate 10 367 
proteins: the capsid (core) protein; envelope glycoproteins E1 and E2; the p7 368 
ion channel; and 6 non-structural proteins (NS2-NS5B).   369 
Chronic infection by HCV is a major risk factor for the onset and 370 
progression of HCC (El-Serag, 2002; Saito et al., 1990). Chronic HCV 371 
infection is responsible for approximately a third of HCCs, and has become 372 
the principal cause of HCC in most industrialized areas. Cirrhosis appears to 373 
be an important nonspecific determinant of HCC occurrence in HCV-infected 374 
patients, and very few cases of HCC without cirrhosis have been reported in 375 
these individuals (Simonetti et al., 1992). 376 
Oxidative stress and elevated reactive oxygen species (ROS) 377 
production are frequently observed during chronic HCV infection. As with 378 
HBV, they are thought to play a central role in HCV-associated HCC. Elevated 379 
levels of oxidative DNA damage (namely 8-OHdG), 4-hydroxynoneal, and 380 
increased lipid peroxidation have been observed in HCV-infected patients 381 
(Farinati et al., 2007b; Kato et al., 2001; Konishi et al., 2006; Mahmood et al., 382 
2004; Shackel et al., 2002). HCV infection has been associated with an 383 
almost fourfold increase in 8-OHdG levels compared to uninfected controls, 384 
and HCV infection induces higher levels of oxidative stress than does HBV 385 
(Farinati et al., 2007b). In line with this, antioxidant therapies are able to 386 
alleviate to some extent the level of hepatic damage in chronic HCV infection, 387 
although there is no clear evidence that antioxidants alone are useful 388 
therapeutic agents in these patients (reviewed by (Singal et al., 2011)). 389 
HCV proteins directly induce oxidative stress 390 
A considerable body of experimental evidence demonstrates a direct 391 
role for the HCV proteins in inducing oxidative stress (Figure 3 lower panel), 392 
from a variety of different models (reviewed in (Ivanov et al., 2013; Simula & 393 
De Re, 2010)). Indeed, FL-N/35 mice transgenic for the entire ORF of HCV 394 
(thus expressing the entire complement of viral proteins) exhibit elevated ROS 395 
levels (Higgs et al., 2012; Nishina et al., 2008), and expression of the HCV 396 
polyprotein induced ROS production (Piccoli et al., 2007). Expression of 397 
several individual HCV proteins have also been linked with overproduction of 398 
ROS, as detailed below. Although a causative role of HCV-associated 399 
oxidative stress in the development of HCC in murine models has yet to be 400 
shown, several studies suggest that oxidative stress induced by the HCV 401 
proteins may trigger genomic instability, eventually leading to HCC. 402 
HCV core and oxidative stress 403 
Although core (and other HCV proteins) primarily localises to the 404 
endoplasmic reticulum, it also associates with mitochondria (Korenaga et al., 405 
2005). Several studies have demonstrated that expression of the HCV core 406 
protein induces oxidative stress, in a variety of experimental systems. Mice 407 
transgenic for core, or for core, E1 and E2, demonstrate increased oxidative 408 
stress and enhanced ROS production (reviewed in (Wang & Weinman, 2006, 409 
2013)).  Moriya and colleagues showed that core induced a shift in the hepatic 410 
oxidant/antioxidant state, leading to mitochondrial damage and possibly 411 
contributing to the onset of HCC in their core-transgenic mice (Moriya et al., 412 
2001). Korenaga et al. demonstrated that core protein associates with 413 
mitochondria and remains associated with the mitochondrial outer membrane 414 
in core-E1–E2 transgenic mice, leading to a disruption of mitochondrial 415 
electron transport complex 1, the generation of ROS and oxidation of the 416 
glutathione pool (Korenaga et al., 2005). Thus it seems that expression of the 417 
HCV core protein provokes mitochondrial dysfunction, leading to oxidative 418 
stress, coupled with activation of components of the intracellular superoxide 419 
scavenging system, including catalase and glutathione (Koike, 2007).  420 
Similar results have been obtained from study of HCV-infected cell 421 
cultures, or of tumoural cells expressing core. Expression of core under the 422 
control of a tetracycline-regulated promoter induced oxidative stress and lipid 423 
peroxidation in HeLa and Huh7 cells (Okuda et al., 2002). Such expression 424 
efficiently induced a cellular antioxidant response, and increased expression 425 
of antioxidant genes (Li et al., 2002). Expression of core (as well as E1 and 426 
NS3) in Huh7 cells leads to an increase in reactive oxygen species (ROS), 427 
and a decrease in mitochondrial permeability (Machida et al., 2006; Pal et al., 428 
2010). Overexpression of core in Huh7 hepatoma cells also increased 429 
mitochondrial Ca2+ uptake, perhaps explaining the increased cytochrome c 430 
release by mitochondria in response to Ca2+ in the presence of core (Li et al., 431 
2002). Similar observations have also been made in vivo in core-transgenic 432 
mice (Korenaga et al., 2005). It is therefore clear that increased mitochondrial 433 
uptake of Ca2+ induced by HCV core stimulates ROS production, leading to 434 
the modification of electron transport components, and inducing cellular 435 
oxidative stress.  436 
The HCV non-structural proteins and oxidative stress 437 
Numerous studies have linked the HCV non-structural proteins, 438 
especially NS3 and NS5A, to oxidative stress. The vast majority of these have 439 
involved expression of a single viral protein in isolation, although expression 440 
of the non-structural HCV proteins also induces ROS (Boudreau et al., 2009; 441 
Rivas-Estilla et al., 2012). Expression of the NS3 protease enhances ROS 442 
production in hepatoma cells (Machida et al., 2006; Pal et al., 2010). Similarly, 443 
NS5A expression in hepatoma cells induces mitochondrial ROS production, 444 
Ca2+ release and activates downstream kinases (Gong et al., 2001; Machida 445 
et al., 2006; Pal et al., 2010). Overproduction of ROS has also been observed 446 
in NS5A-transgenic mice (Wang et al., 2009).  447 
Expression of both NS4B and NS5A also induce ER stress (Gong et 448 
al., 2001; Li et al., 2009). In agreement, Asselah et al. (2010) reported that ER 449 
stress markers were activated in biopsies from HCV-infected patients. 450 
However, transgenic mice expressing low levels of the HCV proteins do not 451 
exhibit ER stress (Lerat et al., 2009). Taken together, these data suggest that 452 
ROS production through HCV-induced ER stress might be linked to HCV 453 
infection rather than HCV protein expression (Asselah et al., 2010).   454 
Recently, we demonstrated both in HCV patients’ biopsies and in the 455 
FL-N/35 mouse lineage (transgenic for the entire ORF of an HCV genotype 1b 456 
isolate, and expressing the full repertoire of HCV proteins at a low level in the 457 
liver), that hepatic c-Myc expression is elevated, increasing ROS production, 458 
and that NS5A is involved in this process (Higgs et al., 2012). It is well 459 
established that expression of the proto-oncogene c-Myc can induce ROS 460 
production (Dang et al., 2005; Graves et al., 2009; Karlsson et al., 2003; Ray 461 
et al., 2006; Vafa et al., 2002). We demonstrated that the increased ROS 462 
production induced by c-Myc is, at least in part, associated with transcriptional 463 
deregulation of cytochrome P2C9 (CYP2C9), a component of the 464 
mitochondrial respiratory chain cytochrome P450 (CYP450).  465 
Limited evidence also suggests that the HCV non-structural proteins, 466 
together with core, repress hepcidin expression in a ROS-dependent manner, 467 
altering iron metabolism (Miura et al., 2008). Importantly, NS5A-induced ROS 468 
production may also impact on glucose production, since an NS5A-dependent 469 
decrease in the phosphorylation of the transcription factor Foxo1 and 470 
subsequently increased glucose production was decreased by N-acetyl 471 
cysteine (Deng et al., 2011). It is probable, therefore, that oxidative stress 472 
induced by HCV impacts on several other HCV-associated pathologies, 473 
including diabetes. 474 
HCV and ROS detoxification 475 
Since oxidative stress is a hallmark of HCV infected cells, the excess 476 
ROS produced are clearly inefficiently detoxified. In an attempt to examine the 477 
impact of HCV on ROS detoxification pathways, several publications have 478 
examined the impact of core and the other HCV proteins on the Nuclear 479 
factor-erythroid 2-related factor 2 (Nrf2) pathway, which is of crucial 480 
importance in the regulation of intracellular oxidation. When associated with 481 
small proteins (sMaf), Nrf2 positively regulates the transcription of genes 482 
containing antioxidant response elements (ARE) in their promoters. (Hirotsu 483 
et al., 2012). Recently, Carvajal-Yepes et al. showed that, in hepatoma cells 484 
harbouring JFH1 replicons, HCV core triggers the delocalization of sMaf 485 
proteins from the nucleus to the endoplasmic reticulum where they bind HCV 486 
NS3. This ultimately restrains Nrf2 from entering into the nucleus and thereby 487 
inhibits the induction of Nrf2/ARE-regulated genes, thus resulting in lower 488 
expression of cytoprotective genes (Carvajal-Yepes et al., 2011). In 489 
contradiction, other published results showed that the overexpression of core, 490 
NS3 and NS5A enhances Nrf2 expression (Ivanov et al., 2011), and that the 491 
Nrf2/ARE antioxidant pathway is activated in cells infected with HCV in vitro, 492 
providing an anti-apoptotic protection mechanism (Burdette et al., 2010). 493 
Further study is therefore necessary to determine how HCV impacts on the 494 
Nrf2/ARE pathway. 495 
Collectively, these studies clearly demonstrate that several of the HCV 496 
proteins (notably core, NS3 and NS5A) induce oxidative stress through a 497 
variety of pathways, thus increasing the likelihood of oxidative DNA damage. 498 
ROS-induced apoptosis and oxidative DNA damage may both contribute to 499 
carcinogenesis, by on the one hand increasing compensatory hepatocellular 500 
proliferation to create a mitogenic and mutagenic environment, whilst on the 501 
other hand inducing further heritable genetic damage.  502 
HCV and oxidative DNA damage 503 
As described above, the role of HCV and the viral proteins in inducing 504 
oxidative stress is well established, and results in the increased 8-OHdG 505 
levels found both in HCV-infected patients, and in HCV-infected cells in vitro. 506 
We have also observed increased levels of single-stranded DNA damage in 507 
mice transgenic for the entire complement of HCV proteins (Higgs et al., 508 
2012). In a manner similar to HBx, several studies have indicated that, in 509 
addition to their role in inducing oxidative stress, HCV core, NS3 and NS5A 510 
may also have deleterious consequences on the repair of oxidative lesions 511 
(amongst other types of DNA damage) (Figure 4).  512 
HCV and the repair of oxidative DNA lesions 513 
There is a relative paucity of studies examining the impact of HCV on 514 
the DNA damage response. Moreover, given the importance of HCV in 515 
inducing oxidative DNA damage, there are surprisingly few reports concerning 516 
HCV and BER. HCV core has been suggested to inhibit the DNA glycosylase 517 
activity responsible for excision of 8-OHdG, although the mechanisms remain 518 
unclear, since core fails to interact with or perturb the expression of the BER 519 
components (Machida et al., 2010a). Pal and colleagues found that 520 
expression of the Neil1 DNA glycosylase (which has marginal activity towards 521 
8-OHdG) was perturbed in HCV-infected cell cultures and biopsies from HCV-522 
infected patients, with a concomitant reduction in Neil1-specific glycosylase 523 
activity, and increased 8-OHdG levels (Pal et al., 2010). Together, these two 524 
reports provide the only preliminary evidence that HCV may have deleterious 525 
consequences on BER. 526 
In a similar manner, there are limited reports that HCV deregulates 527 
NER. We have shown that hepatocytes of mice expressing the HCV proteins 528 
exhibit reduced NER repair by means of a plasmid reactivation assay (Higgs 529 
et al., 2010). Although unconfirmed, it is possible that the reduced expression 530 
of Gadd45β, a p53-response gene linked to NER, plays a contributory role. 531 
Intriguingly, these mice also develop hepatic steatosis (as do many HCV-532 
infected individuals), which, since NER is diminished in steatotic livers 533 
(Schults et al., 2012), may suggest that HCV-induced steatosis contributes to 534 
the observed decrease in NER.  535 
The Ataxia telangiectasia mutated (ATM) kinase plays a key role in the 536 
cellular response to DSBs, and also plays an important role in the response to 537 
oxidative DNA damage (reviewed in (Chen et al., 2012)). ATM is necessary 538 
for repair of ROS-induced DSBs in non-replicating cells (Guo et al., 2010; 539 
Woodbine et al., 2011). Previous reports have suggested that HCV interacts 540 
with ATM, and perturbs its function (Ariumi et al., 2008; Machida et al., 541 
2010b). Thus, it is tempting to speculate that HCV may also disrupt the repair 542 
of DSBs arising from both clustered oxidative lesions as well as exogenous 543 
sources. 544 
A substantial body of evidence demonstrates that various HCV proteins 545 
alter p53 signalling and function in vitro (Alisi et al., 2003; Deng et al., 2006; 546 
Kao et al., 2004; Kwun & Jang, 2003; Lan et al., 2002; Smirnova et al., 2006; 547 
Yamanaka et al., 2002). From these studies, it is apparent that core, NS3 and 548 
NS5A interact with p53, and this interaction seems to inhibit p53 activity, 549 
although the reported consequences are sometimes contradictory. However, 550 
these findings are yet to be repeated in vivo in the various transgenic or 551 
humanised murine models currently available, and these observations may be 552 
a consequence of the use of hepatoma cells and/or of over-expressed 553 
proteins in the majority of these studies. However, it is clear that the impact of 554 
the HCV proteins on p53 function, especially during DNA repair, is worth 555 
further investigation.  556 
From these data, it is apparent that HCV proteins interact with several 557 
DNA repair factors, and may therefore contribute to the elevated levels of 8-558 
OHdG and SSBs observed in HCV-infected individuals by negatively 559 
regulating the repair of oxidative DNA lesions. Clearly future work must focus 560 
on whether HCV perturbs these processes, and on the precise mechanisms 561 
involved. 562 
 563 
CONCLUSIONS AND FUTURE PERSPECTIVES 564 
The causative link between HBV and HCV infection and oxidative DNA 565 
damage is well established. Although a number of mechanistic insights 566 
concerning the ability of virus-infected cells to repair such damage have been 567 
provided from in vitro and in vivo models, it is still not possible to present a 568 
final picture of the effect of the HBV or HCV viral proteins on such repair 569 
processes. Therefore, at present it is probably easier to list the areas 570 
surrounding these viruses and DNA damage which remain to be studied, 571 
rather than those that have been studied.  572 
Clearly, further detailed studies need to be carried out on the ability of 573 
cells expressing the viral HBV or HCV proteins to repair oxidative DNA 574 
lesions, since sustained oxidative damage probably plays a contributory role 575 
in the development of virus-associated HCC. Given the importance of both 576 
viruses in inducing oxidative DNA damage, there is currently a relative lack of 577 
literature on the impact of the viral proteins on BER. On the other hand, 578 
despite a number of publications describing the ability of both viruses to 579 
perturb NER, it is unclear whether this impacts significantly upon oxidative 580 
repair. The eventual impact on virally-associated pathogenesis, including 581 
hepatocellular carcinoma, must also be studied, although this work is 582 
hampered by the lack of current suitable in vivo models for both HBV and 583 
HCV (reviewed by (Lerat et al., 2011)).  Increased future understanding of 584 
how these viruses regulate host cellular DNA repair pathways in response to 585 
oxidative stress will be invaluable in the development of new strategies for the 586 
treatment and prevention of chronic liver diseases.  587 
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FIGURE LEGENDS 595 
Figure 1: Repair of ROS-induced DNA lesions. The majority of oxidative 596 
lesions are repaired by the BER pathway. Oxidative damage is recognised by 597 
a glycosylase (Ogg1 or Neil1 in the case of 8-OHdG), which removes the 598 
altered base. Depending upon the glycosylase involved, this will result in 599 
either a single-stranded break (SSB) or an abasic (AP) site. The latter is then 600 
processed by the Ape1 endonuclease, giving an SSB. These breaks are then 601 
repaired by two subpathways of the BER pathway: short-patch (bottom right) 602 
or long-patch (bottom left). During short-patch BER, DNA polymerase β fills 603 
the gap with a single nucleotide, and the nicked DNA is ligated by XRCC1 and 604 
LigIII. In the alternative long-patch repair, SSBs repair involves the 605 
replacement of 2-12 nucleotides. This is dependent upon synthesis of a new 606 
2-12bp fragment by either Pol β, Pol δ or Pol ε, and the concomitant 607 
displacement of a 5’ DNA flap. This flap is then removed by the enzyme Flap 608 
Endonuclease 1 (FEN1).  Ligation of the nick involves PCNA, LigI and LigIII. 609 
The choice between short-patch repair and long-patch repair (dotted arrows) 610 
is yet to be understood, and is complicated by the high degree of redundancy 611 
between the two pathways. 612 
 613 
Figure 2: Alternative repair of oxidative damage by NER. An unknown 614 
proportion of oxidative lesions may be repaired by nucleotide excision repair 615 
(NER). Two NER subpathways exist, which differ in their ability to detect helix-616 
distorting regions arising anywhere within the genome (global genome NER; 617 
left), or those lesions which arise in the transcribed strands of expressed 618 
genes (transcription coupled NER; right). In both cases, repair is effected 619 
through the actions of detector proteins (XPC and XPE or CSA and CSB) 620 
which recruit TFIIH and its components to the site of damage. TFIIH, XPB and 621 
XPD act in conjunction with XPF and XPG to unwind the DNA surrounding the 622 
lesion and to excise one strand of the unwound bubble. The final stages of 623 
repair involve gap filling by Pol δ or Pol ε, and DNA ligation involving LigIII and 624 
XRCC1. 625 
 626 
Figure 3: Sources of oxidative stress induced by the HBV (upper panel) and 627 
HCV (lower panel) viral proteins. As a result of the innate immune response, 628 
chronic infection with HBV or HCV will induce chronic inflammation, eliciting 629 
ROS production and creating oxidative DNA lesions. Both viruses, and their 630 
proteins, may cause ER stress or induce lipid accumulation, which in turn 631 
leads to oxidative stress and oxidative DNA lesions. In addition, HBx and HCV 632 
Core and NS5A stimulate ROS by perturbing mitochondria function. HCV 633 
NS5A also stimulates c-Myc transcription, leading to perturbation of 634 
cytochrome function and thus mitochondrial ROS, and directly increasing 635 
oxidative stress. In the case of HBV, the resultant oxidative DNA lesions may 636 
contribute to HBV genome integration if left unrepaired. The impact of either 637 
virus on the cellular detoxification of ROS remains unclear (denoted by a ‘?’). 638 
 639 
Figure 4: Interactions between HBV and HCV proteins and the cellular actors 640 
of oxidative DNA repair. (Upper panel): HBV infection upregulates the activity 641 
of the BER glycosylases Neil1 and Ogg1 (green arrows), probably as a 642 
consequence of increased oxidative stress. In contrast, the HCV proteins 643 
inhibit the activity of the Neil1 glycoslyase, and HCV core decreases the 644 
repair of oxidative DNA lesions (red lines). HBx also inhibits the activity of a 645 
third glycosylase, Tdg, although the impact of Tdg on oxidative DNA lesions is 646 
unclear. HBx also inhibits NER by reducing expression of the NER proteins 647 
XPB and XPD, as well as inhibiting transcription-coupled NER. In addition, the 648 
HCV proteins also seem to inhibit NER, perhaps as a consequence of 649 
reduced Gadd45β expression. (Lower panel): A subset of oxidative lesions 650 
are converted into DSBs. HCV non-structural proteins NS3, NS4A and NS5B 651 
are reported to interact with the DSB sensor ATM and inhibit its function. Both 652 
HBx and the HCV core, NS3 and NS5A proteins also inhibit p53 (red lines), 653 
although there are suggestions that Core and NS5A may also stimulate p53 654 
activity (green arrows). 655 
  656 
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